Pure Communications, Inc.

Pure Communications, Inc. http://purecommunicationsinc.com http://purecommunicationsinc.com Pure Communications Inc. is an integrated communications agency specializing in public relations, investor relations and marketing communications for the life sciences industry. http://purecommunicationsinc.comadmin/images/logo.gif Pure Communications, Inc. http://purecommunicationsinc.com en-us Dicerna Closes $25 Million Series B Financing Wed, 11 Aug 2010 05:47:12 EST Pure Communications, Inc. Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure Wed, 14 Jul 2010 07:30:27 EST Pure Communications, Inc. Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma Thu, 08 Jul 2010 10:19:12 EST Pure Communications, Inc. Lilly to Acquire Alnara Pharmaceuticals: Alnara's Pancreatic Enzyme Replacement Therapy, Liprotamase, Currently Under FDA Review Fri, 02 Jul 2010 05:11:15 EST Pure Communications, Inc. AVEO Pharmaceuticals to Close NASDAQ Stock Market on June 22, 2010 Tue, 22 Jun 2010 05:54:59 EST Pure Communications, Inc. Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer Tue, 22 Jun 2010 05:40:06 EST Pure Communications, Inc. VBL Therapeutics Presents Positive Preclinical Data on Immune Modulator in Rheumatoid Arthritis at EULAR Annual Meeting Thu, 17 Jun 2010 08:38:00 EST Pure Communications, Inc. Predictive Biosciences Closes $25 Million Series C Financing Wed, 16 Jun 2010 07:52:24 EST Pure Communications, Inc. Keystone Symposium Highlights Positive Preclinical Data on VBL Therapeutics' Novel Immune Modulator Mon, 07 Jun 2010 05:35:38 EST Pure Communications, Inc. Ablexis Secures $12 Million in Series A Funding to Engineer and Commercialize a Next-Generation Platform for Antibody Drug Discovery Wed, 02 Jun 2010 08:43:30 EST Pure Communications, Inc. WHYY Health + Science Highlights Tengion's Work in Regenerative Medicine, Growing Organs Using a Patient's Own Cells Wed, 26 May 2010 06:58:46 EST Pure Communications, Inc. Predictive Biosciences Announces the Expansion of its Leadership Team and Commercial Sales Force Wed, 26 May 2010 06:12:56 EST Pure Communications, Inc. Lycera Achieves $11 Million Second Tranche in Series A Financing Wed, 28 Apr 2010 06:31:50 EST Pure Communications, Inc. Catabasis Pharmaceuticals Secures $39.6 Million Series A Funding; Breakthrough Approach to Treating Metabolic and Inflammatory Conditions Wed, 21 Apr 2010 08:09:07 EST Pure Communications, Inc. Gemin X Announces $16 Million Series D Financing; Supports Promising Phase 2b Clinical Program for Obatoclax in Small Cell Lung Cancer; Data Expected in 2Q 2010 Tue, 20 Apr 2010 08:21:32 EST Pure Communications, Inc. VBL Therapeutics Announces Preclinical and Clinical Data Demonstrating Substantial Tumor Reduction and Stable Disease Achieved with First-in-Class Vascular Disruptive Agent in Advanced Cancers Mon, 19 Apr 2010 07:31:17 EST Pure Communications, Inc. Foundation Medicine Created by Cancer Genomics Pioneers to Help Bring Personalized Cancer Medicine to Routine Clinical Practice; Company Secures $25 Million Series A Funding Fri, 16 Apr 2010 06:55:38 EST Pure Communications, Inc. Achaogen Completes $56 Million Series C Financing to Advance Clinical Development of Novel Antibiotics to Combat Multi-Drug Resistant Gram-Negative Bacteria and MRSA Thu, 08 Apr 2010 07:24:52 EST Pure Communications, Inc. Dicerna Pharmaceuticals and Ipsen enter into an exclusive research collaboration for the development of new therapeutic agents in endocrinology and oncology Tue, 30 Mar 2010 07:53:57 EST Pure Communications, Inc. InfraReDx's LipiScan Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology Fri, 12 Mar 2010 05:53:35 EST Pure Communications, Inc. Study Demonstrates People Living with Type 2 Diabetes and Obesity Can Be Successfully Treated with GI Dynamics' EndoBarrier Gastrointestinal Liner for 12 Months Wed, 03 Mar 2010 06:21:58 EST Pure Communications, Inc. James Muller to discuss lipid core plaque identification using InfraReDx's LipiScan Coronary Imaging System at CRT 2010 Thu, 18 Feb 2010 11:05:38 EST Pure Communications, Inc. Eleven Biotherapeutics Completes $35 Million Series A Funding to Advance Pipeline of Innovative Protein-Based Therapeutics Wed, 17 Feb 2010 04:24:13 EST Pure Communications, Inc. Trevena, Inc., which is focused on discovering and developing the next generation of G-protein coupled receptor (GPCR) targeted medicines is celebrating the launch of their new website at www.trevenainc.com Tue, 16 Feb 2010 11:15:33 EST Pure Communications, Inc. Trevena Scientific Co-Founder and Scientific Advisory Board Member Robert Lefkowitz Honored with 2009 BBVA Foundation Frontiers of Knowledge Award Wed, 03 Feb 2010 11:57:56 EST Pure Communications, Inc.